Featured Grant OpportunitySchool Emergency Response to Violence (Project SERV) (Funding Opportunity)
Featured Grant OpportunityShare with Youth: NOAA Student Opportunities Database
Featured Grant OpportunityShort Courses in Social Determinants of Health for Research Education in Nursing Research (Funding…
Featured Grant OpportunityComprehensive Partnerships to Advance Cancer Health Equity (CPACHE) Program (Funding Opportunity)
Featured Grant OpportunityResearch and Evaluation on School Safety (Funding Opportunity)
Featured Grant OpportunityLongitudinal Research on Delinquency and Crime (Funding Opportunity)
Featured Grant OpportunityEvaluating Strategies to Advance the Implementation of Evidence-Based Policies and Practices (…
Featured Grant OpportunityMental Health Service Professional (MHSP) Demonstration Grant Program (Funding Opportunity)
Featured Grant OpportunityResearch and Evaluation on Youth Justice Topics (Funding Opportunity)
Featured Grant OpportunityCompetitive Grants for State Assessments Program (Funding Opportunity)
Featured Grant OpportunityResearch on Multidisciplinary Teams (Funding Opportunity)
Featured Grant OpportunityArts Programs for Justice-Involved Youth (Funding Opportunity)
Featured Grant OpportunityCooperative Agreements for the Garrett Lee Smith State/Tribal Youth Suicide Prevention and Early…
Novavax Approved by CDC as an Additional COVID-19 Vaccine for Adolescents
The CDC recently approved Novavax’s COVID-19 vaccine to be used as another primary series option for adolescents ages 12 through 17. This recommendation follows the FDA’s emergency use authorization for the vaccine for this age group.
Novavax uses protein subunit technology, the same technology used in the Influenza and Whooping Cough vaccines, to help the immune system respond to the virus in the future. Learn more.